Literature DB >> 1735568

Renal effects of angiotensin II inhibition during increases in renal venous pressure.

M J Fiksen-Olsen1, D M Strick, H Hawley, J C Romero.   

Abstract

Increases in renal venous pressure have been shown to consistently increase renal interstitial pressure; however, not until renal interstitial pressure is increased threefold is a natriuresis noted in normal animals. Since the intrarenal angiotensin II (Ang II) concentration has been postulated to increase with increasing renal venous pressure, the antinatriuretic action of Ang II could override the natriuretic effect of increased renal interstitial pressure. Therefore, the role of Ang II in the natriuretic response to increased renal venous pressure was examined in 10 pentobarbital-anesthetized dogs. Mean arterial pressure, renal blood flow, renal interstitial pressure, glomerular filtration rate, urinary sodium excretion, plasma renin activity, and prostaglandin E2 excretion were measured at renal venous pressures of 3, 15, and 30 mm Hg. The measurements were repeated after the administration of captopril (1 mg/kg i.v. bolus, n = 5) or [Sar1,Ile8]Ang II (50 micrograms/kg i.v. bolus + 50 micrograms/kg/hr infusion, n = 5). Under control conditions, mean arterial pressure, renal blood flow, plasma renin activity, and prostaglandin E2 excretion remained unchanged when renal venous pressure was increased. The elevations in renal venous pressure increased renal interstitial pressure from 7 +/- 2 to 12 +/- 2 and 22 +/- 4 mm Hg, while sodium excretion remained unchanged until renal venous pressure was 30 mm Hg. In the captopril-treated group, increasing renal venous pressure increased renal interstitial pressure as under control conditions; however, sodium excretion (23 +/- 4, 19 +/- 4, and 27 +/- 6 mueq/min) was not significantly increased even at the highest renal venous pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735568     DOI: 10.1161/01.hyp.19.2_suppl.ii137

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  The kidney in heart failure: an update.

Authors:  Kevin Damman; Jeffrey M Testani
Journal:  Eur Heart J       Date:  2015-04-02       Impact factor: 29.983

Review 2.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.

Authors:  Paolo C Colombo; Anjali Ganda; Jeffrey Lin; Duygu Onat; Ante Harxhi; Julia E Iyasere; Nir Uriel; Gad Cotter
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 3.  The acute cardiorenal syndrome: burden and mechanisms of disease.

Authors:  Petra Nijst; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 4.  Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.

Authors:  Iris E Beldhuis; Carolyn S P Lam; Jeffrey M Testani; Adriaan A Voors; Harriette G C Van Spall; Jozine M Ter Maaten; Kevin Damman
Journal:  Circulation       Date:  2022-02-28       Impact factor: 39.918

Review 5.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

6.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; David O Taylor; Randall C Starling; James B Young; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

Review 7.  The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure.

Authors:  Pierpaolo Di Nicolò
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

Review 8.  Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications.

Authors:  Wilfried Gyselaers
Journal:  J Clin Med       Date:  2019-03-11       Impact factor: 4.241

9.  AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats.

Authors:  Vojtech Kratky; Zdenka Vanourkova; Matus Sykora; Barbara Szeiffova Bacova; Zdenka Hruskova; Sona Kikerlova; Zuzana Huskova; Libor Kopkan
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

Review 10.  Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach.

Authors:  Victor Sarli Issa; Lúcia Andrade; Edimar Alcides Bocchi
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.